NEW YORK, Oct. 19, 2016 /PRNewswire/ -- Plaintiffs who allegedly suffered serious kidney injuries, including chronic kidney disease or kidney failure, related to the use of Nexium or another proton pump inhibitor have asked a judicial panel to ... TickerTech.com, 5 days ago
As Proton Pump Inhibitor Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Suggesting Many Long-Term Users Continue to Struggle with GERD Symptoms - 4 Traders, 1 week ago
2 images for "Zegerid"
Financial Guidance for 2016 There are several reasons that can help one conclude that Valeant Pharmaceutical's (NYSE: VRX ) financial guidance for 2016 may be too optimistic. The company has projected that it will earn revenues in the range of ...Seeking Alpha, 1 week ago Recent Analysts Ratings Changes for Valeant Pharmaceuticals International (VRX) SleekMoney, 1 month ago Weekly Analysts Ratings Changes for Valeant Pharmaceuticals International (VRX) SleekMoney, 1 month ago Valeant Pharmaceuticals International (VRX) Research Analysts Weekly Ratings Changes American Banking News, 1 month ago
While the stock's re-rated on account of hopes on several fronts, the pipeline isn't sufficient to offset competitive pressures on the US biz. DRRD shares re-rated by 10% post Q1FY17 correction on hopes of earnings accretion from Teva portfolio ...Financial Express, 3 weeks ago
BRIDGEWATER, N.J. , Sept. 26, 2016 /PRNewswire/ -- Ajanta Pharma USA Inc., a wholly owned subsidiary of Ajanta Pharma Ltd, announces today the launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension, a bioequivalent prescription ...WorldNetDaily, 4 weeks ago Ajanta Launches Omeprazole and Sodium Bicarbonate Powder for Oral Suspension American Pharmaceutical Review, 3 weeks ago Ajanta Pharma announces US FDA approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension India PRwire, 2 months ago Ajanta Pharma hits new high on USFDA approval; shares up 3% Money Control, 2 months ago
Nexium Lawsuit Filed By Bernstein Liebhard LLP On Behalf of Illinois Man Who Developed Chronic Kidney Disease Allegedly Related to Use of the Proton Pump Inhibitor
NEW YORK, Sept. 19, 2016 /PRNewswire/ --The nationwide law firm of Bernstein Liebhard LLP announces that they have filed a Nexium lawsuit ( http://www.nexiumlawsuit.com/ ) on behalf of an Illinois man who developed chronic kidney disease allegedly ...Yahoo! Finance, 1 month ago
Home » Health » / no comments The price ofone of the most commonly prescribed treatments for Parkinson's disease hassurged more than 200 percent over the past decade. That's making the drug,Teva Pharmaceutical'sAzilect,unaffordable for some ...HealthMediciNet.com, 1 month ago
(Before It's News) Oftwominds.com s eclectic range of timely topics include finance, economy, stocks, housing, Asia, energy, long-term trends, social issues, urban planning, work/tradecraft, health/diet/fitness, sustainability, Les Paul guitars ...Before It's News, 2 months ago
More from: , PrisonPlanet...and 2 other sources
Posted by Equitymaster Global markets closed on a mixed note in the week gone by. Stock indices in Germany (up 1.9%) and France (up 1.3%) were the leading gainers in the pack. While Singapore (down 2.6%) and Chinese (down 1.1%) stock indices were among the ...Equitymaster.com, 2 months ago
Posted by Equitymaster Indian indices continue to languish in the negative territory during the post-noon trading session. Sectoral indices are trading on a mixed note with stocks from the healthcare , oil & gas sectors leading the gains. consumer durables ...Equitymaster.com, 2 months ago
on your WebpageAdd Widget >Get your members hooked!